Incidence and Prevalence of Antiepileptic Medication use in Community-Dwelling Persons with and without Alzheimer’s Disease

Manuscript Number: 

18-0594R1

Author(s): 
Sirpa Hartikainen, Piia Lavikainen, Tatyana Sarycheva, Heidi Taipale, Antti Tanskanen, Jari Tiihonen, Anna-Maija Tolppanen

Disclosures

Sirpa Hartikainen

  • Nothing to Disclose

Piia Lavikainen

  • Nothing to Disclose

Tatyana Sarycheva

  • Nothing to Disclose

Heidi Taipale

  • Grants
    • Agency: 
      Janssen Cilag
      Dates: 
      2017
    • Agency: 
      Eli Lilly
      Dates: 
      2016

Antti Tanskanen

  • Consulting Fees:
    Janssen advisory board

Jari Tiihonen

  • Consulting Fees:
    Consultant to Lundbeck, Organon, Janssen-Cilag, Eli Lilly, AstraZeneca, F. Hoffman-La Roche, and Bristol-Myers Squibb. Fees for giving expert opinions to Bristol-Myers Squibb, and GlaxoSmithKline. Advisory Board member in AstraZeneca, Janssen-Cilag, Otsuka.
    Lecture Fees:
    Lecture fees from Janssen-Cilag, Bristol-Myers Squibb, Eli Lilly, Pfizer, Lundbeck, GlaxoSmithKline, AstraZeneca, Novartis
    Grants
    • Agency: 
      Eli Lilly
      Dates: 
      2017 - 2019
    • Agency: 
      Janssen-Cilag
      Dates: 
      2017 - 2019
    • Agency: 
      Stanley Foundation
      Dates: 
      2012- 2013

Anna-Maija Tolppanen

  • Nothing to Disclose